Pfizer Interest Coverage vs Inventory Turnover Analysis

PFE Stock  USD 27.75  0.03  0.11%   
Pfizer financial indicator trend analysis is much more than just breaking down Pfizer Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pfizer Inc is a good investment. Please check the relationship between Pfizer Interest Coverage and its Inventory Turnover accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

Interest Coverage vs Inventory Turnover

Interest Coverage vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pfizer Inc Interest Coverage account and Inventory Turnover. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Pfizer's Interest Coverage and Inventory Turnover is 0.43. Overlapping area represents the amount of variation of Interest Coverage that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of Pfizer Inc, assuming nothing else is changed. The correlation between historical values of Pfizer's Interest Coverage and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Coverage of Pfizer Inc are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Interest Coverage i.e., Pfizer's Interest Coverage and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

0.43
Relationship DirectionPositive 
Relationship StrengthWeak

Interest Coverage

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most indicators from Pfizer's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
As of March 29, 2024, Selling General Administrative is expected to decline to about 13.8 B. In addition to that, Discontinued Operations is expected to decline to about 5.1 M
 2021 2022 2023 2024 (projected)
Gross Profit50.5B66.0B29.3B30.4B
Total Revenue81.3B100.3B58.5B39.5B

Pfizer fundamental ratios Correlations

0.850.70.880.770.840.820.770.250.970.560.440.540.580.930.730.6-0.120.980.710.640.350.870.840.870.91
0.850.60.850.40.60.990.750.070.930.350.00.180.270.840.530.8-0.350.90.70.210.510.850.60.80.7
0.70.60.870.520.580.610.79-0.070.70.840.160.340.070.440.590.72-0.440.640.920.36-0.120.490.580.890.54
0.880.850.870.590.730.850.9-0.010.910.680.120.370.20.710.730.74-0.470.880.840.370.350.720.730.960.78
0.770.40.520.590.920.370.550.30.660.670.640.720.590.660.870.20.080.680.460.860.210.550.920.620.81
0.840.60.580.730.920.580.630.240.790.620.410.720.540.760.950.31-0.050.80.570.710.370.671.00.720.87
0.820.990.610.850.370.580.79-0.060.910.36-0.070.110.190.790.520.83-0.440.880.710.150.510.810.580.80.68
0.770.750.790.90.550.630.79-0.240.820.680.050.13-0.020.60.70.79-0.710.760.840.280.280.540.630.920.78
0.250.07-0.07-0.010.30.24-0.06-0.240.14-0.050.50.580.650.350.09-0.270.650.23-0.10.470.060.260.24-0.020.16
0.970.930.70.910.660.790.910.820.140.560.220.410.440.910.70.71-0.260.980.760.440.420.90.790.90.86
0.560.350.840.680.670.620.360.68-0.050.560.170.390.040.280.640.52-0.340.460.760.37-0.120.360.620.760.45
0.440.00.160.120.640.41-0.070.050.50.220.170.550.720.440.29-0.170.480.350.00.91-0.130.210.410.130.48
0.540.180.340.370.720.720.110.130.580.410.390.550.760.460.61-0.220.460.460.240.730.050.410.720.350.52
0.580.270.070.20.590.540.19-0.020.650.440.040.720.760.670.31-0.160.70.530.020.760.120.580.540.180.52
0.930.840.440.710.660.760.790.60.350.910.280.440.460.670.610.490.030.960.510.60.470.890.760.680.87
0.730.530.590.730.870.950.520.70.090.70.640.290.610.310.610.31-0.260.70.580.610.390.490.950.70.83
0.60.80.720.740.20.310.830.79-0.270.710.52-0.17-0.22-0.160.490.31-0.640.620.82-0.030.120.560.310.760.41
-0.12-0.35-0.44-0.470.08-0.05-0.44-0.710.65-0.26-0.340.480.460.70.03-0.26-0.64-0.17-0.530.34-0.170.05-0.05-0.48-0.21
0.980.90.640.880.680.80.880.760.230.980.460.350.460.530.960.70.62-0.170.680.550.460.890.80.840.9
0.710.70.920.840.460.570.710.84-0.10.760.760.00.240.020.510.580.82-0.530.680.22-0.10.530.570.890.57
0.640.210.360.370.860.710.150.280.470.440.370.910.730.760.60.61-0.030.340.550.220.030.380.710.380.7
0.350.51-0.120.350.210.370.510.280.060.42-0.12-0.130.050.120.470.390.12-0.170.46-0.10.030.430.370.20.43
0.870.850.490.720.550.670.810.540.260.90.360.210.410.580.890.490.560.050.890.530.380.430.670.730.68
0.840.60.580.730.921.00.580.630.240.790.620.410.720.540.760.950.31-0.050.80.570.710.370.670.720.87
0.870.80.890.960.620.720.80.92-0.020.90.760.130.350.180.680.70.76-0.480.840.890.380.20.730.720.76
0.910.70.540.780.810.870.680.780.160.860.450.480.520.520.870.830.41-0.210.90.570.70.430.680.870.76
Click cells to compare fundamentals

Pfizer Account Relationship Matchups

Pfizer fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets167.5B154.2B181.5B197.2B226.5B237.8B
Short Long Term Debt Total52.1B38.3B37.0B34.9B75.0B78.8B
Total Current Liabilities37.3B25.9B42.7B42.1B47.8B50.2B
Total Stockholder Equity63.1B63.2B77.2B95.7B89.0B46.9B
Property Plant And Equipment Net14.0B13.9B14.9B16.3B18.9B11.3B
Net Debt50.8B36.5B35.1B34.5B72.2B75.8B
Retained Earnings97.7B96.8B103.4B125.7B118.4B124.3B
Cash1.3B1.8B1.9B416M2.9B2.0B
Non Current Assets Total134.7B119.2B121.8B145.9B183.2B192.3B
Non Currrent Assets Other4.5B4.6B7.7B13.2B9.1B5.3B
Cash And Short Term Investments9.8B12.2B31.1B22.7B12.7B14.9B
Net Receivables12.1B11.2B15.7B14.5B11.2B8.7B
Common Stock Shares Outstanding5.7B5.6B5.7B5.7B5.7B6.3B
Liabilities And Stockholders Equity167.5B154.2B181.5B197.2B226.5B237.8B
Non Current Liabilities Total66.7B64.8B61.3B59.2B89.4B93.9B
Inventory8.3B8.0B9.1B9.0B10.2B5.2B
Other Current Assets2.6B3.4B3.8B5.0B9.3B9.7B
Other Stockholder Equity(23.4B)(22.3B)(20.8B)(22.2B)(21.9B)(20.8B)
Total Liab104.0B90.8B104.0B101.3B137.2B144.1B
Property Plant And Equipment Gross14.0B28.4B30.0B31.4B35.0B36.7B
Total Current Assets32.8B35.1B59.7B51.3B43.3B32.2B
Short Term Debt16.2B2.7B2.2B2.9B10.9B5.7B
Intangible Assets35.4B28.5B25.1B43.4B64.9B68.1B
Property Plant Equipment14.0B13.9B14.9B16.3B18.9B11.3B
Accounts Payable4.2B4.3B5.6B6.8B6.7B7.0B
Accumulated Other Comprehensive Income(11.6B)(11.7B)(5.9B)(8.3B)(8.0B)(7.6B)
Common Stock Total Equity468M470M473M476M478M474.0M
Short Term Investments8.5B10.4B29.1B22.3B9.8B9.3B
Common Stock468M470M473M476M478M474.0M
Other Liab29.7B26.6B22.6B23.3B26.9B22.1B
Other Assets4.2B4.3B5.6B6.8B6.7B5.0B
Long Term Debt36.0B37.1B36.2B32.9B60.5B63.5B
Good Will58.7B49.6B49.2B51.4B67.8B40.7B
Treasury Stock(110.8B)(111.0B)(111.4B)(114.0B)(114.5B)(108.8B)
Current Deferred Revenue5.8B6.3B3.1B2.5B2.7B3.9B
Net Tangible Assets(30.9B)63.2B77.2B95.7B89.0B93.5B
Noncontrolling Interest In Consolidated Entity303M235M262M256M274M265.1M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.